# Sublingual Apomorphine in Refractory Restless Legs Syndrome

> **NCT05529095** · PHASE4 · UNKNOWN · sponsor: **William Ondo, MD** · enrollment: 16 (estimated)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Apomorphine Sublingual Film
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05529095
- **Lead sponsor:** William Ondo, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2022-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529095, "Sublingual Apomorphine in Refractory Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05529095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*